Search Protocols under revision. Back New search Go to resultsDiseaseMain groupSupportive Therapy, ToxicityProtocol groupComplicationsDiseaseCardiotoxicitySubgroupICD10I42.7MeSHCardiotoxicitySequenceChemotherapyChemo-substanceChemo-substanceChemo-substanceChemo-substanceNo. Substances RadiotherapySupportive therapySupportive substanceDexrazoxaneSupportive substanceDexrazoxaneSupportive substanceDexrazoxaneSupportive substanceDexrazoxaneNo. Substances1Protocol classificationTherapy classificationcurrent standardIntensityStandard doseTherapy indicationTherapy phaseTherapy intentionsupportiveRisksAnemia Hb below 8g/dlDiarrheaEmetogenicityInfectionsNauseaNeutropenia only studiesPublicationAuthordeBaat EDiseaseAnthrazyklintherapie bei Kindern und Erwachsenen, Kardioprotektion bei kumulativer DosisOriginPrincess Máxima Center for Pediatric Oncology, Utrecht, NetherlandsProtokolle in Überarbeitung 2 protocols foundDexrazoxane 500, Cardiotoxicity Associated with Doxorubicin (PID3269 V1.0)Dexrazoxane 600, Cardiotoxicity Associated with Epirubicin (PID3266 V1.0)
